King Trumpet and Bone Health: Osteoporosis Research

King Oyster Mushroom

Dual action: promotes bone formation AND blocks bone breakdown

King trumpet mushroom (Pleurotus eryngii) contains compounds that simultaneously promote osteoblast differentiation (the cells that build new bone) and inhibit osteoclast formation (the cells that resorb bone). This dual mechanism positions it among the most pharmacologically interesting mushrooms for bone health research.

Kim et al., 2006; Yokoyama et al., 2012; Lindequist et al., 2021

25(OH)D2

serum vitamin D2 metabolite significantly increased in humans consuming UV-B irradiated king trumpet mushrooms in a 2022 RCT (Kleftaki et al.)

Up to 62%

inhibition of osteoclast differentiation by ergosterol peroxide isolated from P. eryngii, at 1.0 µg/mL with low cytotoxicity (Yokoyama et al., 2012)

Most preclinical

the vast majority of king trumpet bone health evidence is in vitro or animal models; the 2022 Kleftaki RCT is the only human clinical data

Kim et al., 2006; Yokoyama et al., 2012; Lindequist et al., 2021

View as image ↗

Bone health involves two simultaneous processes: formation of new bone by osteoblasts and resorption of old bone by osteoclasts. Osteoporosis occurs when resorption outpaces formation, gradually reducing bone density. Effective approaches to bone health therefore need to address both sides of this balance.

King trumpet mushroom (Pleurotus eryngii) is unusual among dietary plants and fungi because research has documented activity on both sides. Two separate compound pathways operate simultaneously: ergosterol conversion to vitamin D2 (which promotes osteoblast-mediated bone formation) and ergosterol peroxide (which directly inhibits osteoclast formation through a different mechanism). A 2021 medicinal mushroom review specifically identified Pleurotus eryngii among the most promising species for osteoporosis research precisely because of this dual action.^[6]

This article explains both mechanisms and situates them within the evidence hierarchy, including the only human clinical data available. For context on what king trumpet provides nutritionally, see what is king trumpet mushroom: the meaty mushroom with health benefits.

The Human Clinical Hook: Kleftaki 2022

The strongest evidence for king trumpet's bone-health relevance comes from a randomized controlled trial published in 2022. Kleftaki and colleagues enrolled adults with metabolic disorders in a trial that included consumption of UV-B irradiated Pleurotus eryngii mushrooms and measured multiple metabolic and nutritional markers.^[7]

The bone-relevant finding: participants who consumed the UV-B irradiated king trumpet mushrooms showed significantly higher serum 25(OH)D2 levels compared to baseline and control groups. 25-hydroxyvitamin D2 (25(OH)D2) is the circulating form of vitamin D2 produced when the liver converts dietary vitamin D2. It is the standard clinical marker for vitamin D2 status. Higher 25(OH)D2 levels are associated with better calcium absorption and bone mineral density maintenance.

This is the only human clinical evidence directly connecting king trumpet mushroom consumption to a bone-health relevant biomarker. The other evidence in this article is preclinical (in vitro and animal models). Kleftaki 2022 establishes that eating king trumpet mushrooms is sufficient to raise circulating vitamin D2 metabolites in humans, the first step in a causal chain toward bone health benefits.

The study did not measure bone density directly, and the metabolic disorder population is not directly generalizable to osteoporosis prevention. But it confirms the biological plausibility of the vitamin D2 pathway in living humans.

The Only Human Data

Kleftaki et al. (2022) · Antioxidants (Basel)

Population

100 adults with metabolic disorders, randomized to two arms

Intervention

A daily baked, UV-B irradiated Pleurotus eryngii mushroom snack for 3 months, on top of standard nutritional counseling

Comparator

Nutritional counseling alone (control arm)

Finding

Participants eating the UV-B irradiated king trumpet snack showed significantly higher serum 25(OH)D2 — the main circulating vitamin D2 metabolite and standard clinical marker, tied to calcium absorption and bone mineral density — versus control. Bone density itself was not measured.

preliminary A biomarker result in a metabolic-disorder population, not a bone-outcome trial. It establishes the first link in the causal chain, not the end of it.

Kleftaki et al., 2022

Two Mechanisms: Bone Building and Bone Breakdown

King trumpet's bone health effects work through two separate compound pathways that address both sides of the bone remodeling equation.

Mechanism 1 (Vitamin D2 pathway): King trumpet contains ergosterol that converts to vitamin D2 under UV-B light (or through UV lamp treatment). Dietary vitamin D2 is converted to the active metabolite 25(OH)D2 in the liver. Vitamin D2 promotes calcium absorption in the gut and stimulates osteoblast differentiation (the cells that produce new bone matrix). This is the classical vitamin D2 pathway and is shared with other vitamin D2-containing foods.

Mechanism 2 (Ergosterol peroxide pathway): King trumpet also contains ergosterol peroxide, a specific oxidized derivative of ergosterol. This compound inhibits osteoclast formation through a different and more direct pathway. Osteoclasts are the cells that resorb (break down) old bone tissue; excessive osteoclast activity relative to osteoblast activity is the core imbalance in osteoporosis. Ergosterol peroxide suppresses this process independent of vitamin D2 signaling.

The combination of promoting bone formation (via vitamin D2) and blocking bone resorption (via ergosterol peroxide) makes king trumpet's bone-related compound profile mechanistically distinctive. Most dietary interventions for bone health address one side of this balance; king trumpet research has documented activity on both.

The Foundational In Vitro Evidence: Kim 2006

The foundational evidence establishing both sides of king trumpet's bone effects comes from Kim and colleagues, published in 2006.^[1]

Kim's team tested Pleurotus eryngii extracts on bone cell cultures, measuring both osteoblast differentiation (the bone-building pathway) and osteoclast formation (the bone-resorbing pathway). The results demonstrated:

• P. eryngii extracts promoted osteoblast differentiation in cell culture, measured by alkaline phosphatase activity and bone mineral nodule formation (markers of active bone-building)
• The same extracts reduced osteoclast formation from precursor cells, measured by TRAP-positive cell counts (a standard marker for osteoclast activity)

This in vitro study established that king trumpet contains compounds active on both bone cell populations, providing the mechanistic foundation for subsequent research. The specific compounds responsible for each effect were identified in subsequent work.

Ergosterol Peroxide: The Osteoclast Inhibitor

Yokoyama and colleagues specifically isolated ergosterol peroxide from Pleurotus eryngii and tested its osteoclast-inhibiting activity in 2012.^[2]

The context: osteoclast formation is normally driven by RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). When RANKL binds its receptor on pre-osteoclast cells, it triggers their differentiation into active, bone-resorbing osteoclasts — the process osteoporosis therapies aim to blunt. What Yokoyama's team demonstrated is that ergosterol peroxide inhibits this differentiation step: the compound reduced osteoclast formation in a dose-dependent manner, achieving up to 62% inhibition at a concentration as low as 1.0 µg/mL, with low cytotoxicity. The study established that the compound suppresses osteoclast differentiation; it did not map which specific node in the RANKL cascade the compound acts on, so the precise molecular target within that pathway remains uncharacterized.

Yokoyama's work provided the specific compound identity behind the osteoclast-inhibiting activity documented by Kim in 2006. Ergosterol peroxide from king trumpet, not just an unspecified extract, produces the effect — and it does so potently, at low micromolar concentrations without harming the cells.

This matters for understanding king trumpet's relevance to bone health: the anti-resorptive activity traces to a specific identified molecule with a quantified potency, not to a complex mixture of unknown compounds.

The Animal Study: Ovariectomized Rats

Ohyama and colleagues (2014) took the preclinical evidence one step further by testing P. eryngii ethanol extract in an animal model of postmenopausal osteoporosis.^[3]

Ovariectomized rats develop accelerated bone loss that mimics postmenopausal osteoporosis in humans, driven by estrogen deficiency. Treating ovariectomized rats with P. eryngii extract produced significant preservation of bone density compared to untreated controls. Bone mineral density markers were meaningfully higher in the extract-treated group.

The animal model is a meaningful step above cell culture evidence because it involves the full complexity of a living organism, systemic metabolism of the mushroom compounds, and a disease model with direct relevance to human osteoporosis. The limitation is that animal-to-human translation is imperfect: the doses, preparation, and biological specifics of rat bone metabolism differ from human metabolism.

The Vitamin D2 Connection

Chen and colleagues (2015) addressed the bone health implications of vitamin D2-enhanced mushroom consumption more broadly, examining whether consuming mushrooms specifically enriched for vitamin D2 (through UV-B treatment) was associated with improved bone health markers.^[4]

The study found that vitamin D2-enhanced mushroom consumption was associated with improved bone health outcomes, supporting the vitamin D2 pathway as clinically meaningful beyond just raising serum levels. Combined with Kleftaki's 2022 demonstration that king trumpet specifically raises 25(OH)D2 in humans, there is a two-step research chain: king trumpet raises vitamin D2 metabolites (Kleftaki) and raised vitamin D2 from mushrooms associates with better bone health (Chen).

Where King Trumpet Stands Among Mushrooms for Bone Health

Erjavec and colleagues (2016) compared extracts from multiple mushroom species for their effects on both bone resorption and bone formation markers, providing a cross-species context for king trumpet's bone effects.^[5] The comparison included several species. P. eryngii showed activity in both directions (reducing resorption markers and improving formation markers) consistent with the mechanism documented by Kim and Yokoyama.

Lindequist and colleagues (2021) published a review specifically on medicinal mushrooms for osteoporosis prevention and therapy, surveying the evidence across species.^[6] The review identified Pleurotus eryngii among the most promising species for further investigation, citing the dual mechanism evidence and positioning it within the broader landscape of mushroom bone health research.

The Honest Evidence Assessment

The evidence for king trumpet and bone health spans three tiers with very different confidence levels:

Human clinical data (Kleftaki 2022): Confirmed that consuming king trumpet raises 25(OH)D2 levels in humans. This is the only human trial, and it measured a biomarker (vitamin D2 metabolite), not bone density directly.

Animal model data (Ohyama 2014): Confirmed that P. eryngii extract preserves bone density in an ovariectomized rat model. Relevant disease model, but human translation is uncertain.

In vitro data (Kim 2006, Yokoyama 2012): Established both sides of the dual mechanism (osteoblast promotion, osteoclast inhibition) with identified compounds and, for ergosterol peroxide, a quantified potency (up to 62% osteoclast-differentiation inhibition at 1.0 µg/mL). Strong mechanistic foundation, but cell culture does not confirm dietary relevance.

Evidence Hierarchy

King Trumpet & Bone Health — Strong Preclinical Base, One Human Biomarker, One Missing Rung

The bone-health case is built bottom-up: cell studies establishing the dual mechanism, an ovariectomized-rat model, and a single human RCT that measured a vitamin D2 biomarker — not bone density itself. Bar width reflects how much direct evidence sits at each tier; narrower toward the top means closer to a human bone outcome but less data.

Cell & isolated-compound studies

evidence

Kim 2006 · Yokoyama 2012 · Erjavec 2016

P. eryngii extract raised osteoblast bone-building markers and cut osteoclast formation in culture; the isolated compound ergosterol peroxide inhibited osteoclast differentiation by up to 62% at 1.0 µg/mL with low cytotoxicity; cross-species work confirmed resorption down and formation up

Whole-organism animal model

evidence

Ohyama 2014

P. eryngii ethanol extract preserved bone density in ovariectomized rats — the standard model for postmenopausal, estrogen-deficiency bone loss

Human biomarker RCT

evidence

Kleftaki 2022 · Chen 2015

A three-month randomized controlled trial found UV-B irradiated king trumpet raised serum 25(OH)D2, the main circulating vitamin D2 metabolite tied to calcium absorption and bone density; separate work links vitamin D2–enhanced mushrooms to better bone health

Human bone-density trial

gap

Does not yet exist

No study has measured bone mineral density, fracture risk, or any bone outcome directly after king trumpet consumption in people. The vitamin D2 rise is the first step in a causal chain, not proof of bone benefit

How to read it: the cell and animal tiers converge across independent labs on a genuine dual mechanism — promoting bone formation and blunting bone breakdown — which is why the lower bars are wide and solid. King trumpet also reaches human data, but that single RCT measured a vitamin D2 metabolite in people with metabolic disorders, not bone density. The trial that would confirm a real bone benefit — tracking bone mineral density after sustained king trumpet consumption — has not been run. That gap, not the strength of the lower tiers, is the honest limit of the story.

Sources: Kim 2006 [1]; Yokoyama 2012 [2]; Ohyama 2014 [3]; Chen 2015 [4]; Erjavec 2016 [5]; Kleftaki 2022 [7]. Bar widths are illustrative of evidence depth per tier, not quantitative effect sizes.

Taken together: king trumpet has mechanistically sound and multi-level preclinical evidence for bone health, with one piece of human biomarker data. A human trial measuring bone mineral density after extended king trumpet consumption would be the next needed evidence. That trial has not been conducted.

Important Context

Low

This Is Research, Not Medical Advice

Concern

Osteoporosis and low bone density are medical conditions that require professional diagnosis and management. No mushroom — king trumpet included — has been shown in a human trial to prevent fractures or improve bone mineral density, and none should be used in place of proven therapies (adequate calcium and vitamin D, weight-bearing exercise, and prescribed medications where indicated).

What the research says

Treat king trumpet as a nutritious food with promising preclinical bone-health research, not as a treatment. If you have or are at risk for osteoporosis, decisions about supplements, diet, and medication belong with your physician.

Particularly relevant for: Anyone with diagnosed osteoporosis, osteopenia, or elevated fracture risk

What to do

Discuss any bone-health strategy — including dietary changes and UV-B mushroom consumption for vitamin D2 — with a qualified healthcare provider before relying on it.

RethinkMushrooms editorial standard; evidence base summarized above

The Bottom Line

King trumpet mushroom has documented activity on both sides of bone remodeling: ergosterol peroxide inhibits osteoclast differentiation dose-dependently (up to 62% at 1.0 µg/mL with low cytotoxicity; Yokoyama et al., 2012) while the vitamin D2 pathway promotes osteoblast differentiation and calcium absorption. Kleftaki et al. (2022) in a human RCT confirmed that UV-B irradiated king trumpet mushrooms significantly increase serum 25(OH)D2, the only human clinical data connecting king trumpet to a bone-relevant biomarker. Kim et al. (2006) provided the foundational in vitro dual-mechanism evidence; Ohyama et al. (2014) confirmed bone density preservation in an ovariectomized rat model. No human trial has measured bone mineral density outcomes from king trumpet consumption.

Frequently Asked Questions

Is king trumpet mushroom good for bones?

King trumpet mushroom (Pleurotus eryngii) contains compounds documented to act on both sides of bone remodeling in preclinical research: vitamin D2 (promotes osteoblast-mediated bone formation and calcium absorption) and ergosterol peroxide (inhibits osteoclast differentiation dose-dependently, up to 62% at 1.0 µg/mL in cell studies). A 2022 human RCT confirmed that consuming UV-B irradiated king trumpet raises serum 25(OH)D2 levels (Kleftaki et al.), connecting dietary consumption to a bone-relevant biomarker. No human trial has directly measured bone density outcomes.

Can mushrooms help prevent osteoporosis?

Several mushrooms show bone health-relevant activity in preclinical research, including king trumpet, reishi, and others. The most direct human-relevant pathway is vitamin D2 from UV-B treated mushrooms, which raises circulating 25(OH)D2 and supports calcium absorption. King trumpet's ergosterol peroxide additionally inhibits osteoclast formation in cell culture and animal models. Lindequist et al.'s 2021 review identifies mushrooms as a potentially significant dietary intervention for osteoporosis, though large-scale human bone density trials are lacking.

What compound in king trumpet mushroom helps bones?

Two compounds: ergosterol (which converts to vitamin D2 under UV-B light, supporting the classical vitamin D pathway for bone formation) and ergosterol peroxide (a specific oxidized derivative that inhibits osteoclast differentiation — the maturation of bone-resorbing cells that RANKL normally drives). Yokoyama et al. (2012) isolated ergosterol peroxide from P. eryngii and showed it inhibits osteoclast differentiation dose-dependently, up to 62% at 1.0 µg/mL with low cytotoxicity.

Does Pleurotus eryngii have any bone health benefits?

Yes, at the preclinical level. P. eryngii extracts promote osteoblast differentiation and inhibit osteoclast formation in cell culture (Kim et al., 2006); ergosterol peroxide from P. eryngii inhibits osteoclast differentiation dose-dependently, up to 62% at 1.0 µg/mL (Yokoyama et al., 2012); ethanol extract of P. eryngii preserves bone density in ovariectomized rats (Ohyama et al., 2014). In humans, UV-B irradiated P. eryngii consumption increases serum 25(OH)D2 (Kleftaki et al., 2022). Direct bone density measurement in human clinical trials has not been conducted.

Which mushrooms are best for osteoporosis?

Research on multiple mushroom species has found bone health activity. King trumpet is notable for its dual mechanism (both promoting bone formation and inhibiting resorption) with specific compound identification. Other species with documented bone-relevant activity include reishi (Ganoderma lucidum, with polysaccharide data), shiitake (vitamin D2 and lentinan), and chaga (antioxidant mechanisms). Lindequist et al.'s 2021 comprehensive review concluded that Pleurotus species show among the most promising profiles for osteoporosis research based on available preclinical evidence.

Sources & References

1. 1RTHM-00192·Kim, Se-Won et al. (2006). “Effects of mushroom, Pleurotus eryngii, extracts on bone metabolism..” Clinical nutrition (Edinburgh.Study breakdown →PubMed →↩
2. 2RTHM-00503·Yokoyama, Satoru et al. (2012). “Osteoclastogenesis inhibitory effect of ergosterol peroxide isolated from Pleurotus eryngii..” Natural product communications.Study breakdown →PubMed →↩
3. 3RTHM-00341·Ohyama, Y et al. (2014). “Effect of the ethanol extract of Pleurotus eryngii on bone metabolism in ovariectomized rats..” Climacteric : the journal of the International Menopause Society.Study breakdown →PubMed →↩
4. 4RTHM-00677·Chen, Shin-Yu et al. (2015). “Consumption of vitamin D2 enhanced mushrooms is associated with improved bone health..” The Journal of nutritional biochemistry.Study breakdown →PubMed →↩
5. 5RTHM-00424·Erjavec, Igor et al. (2016). “Mushroom Extracts Decrease Bone Resorption and Improve Bone Formation..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
6. 6RTHM-00701·Lindequist, Ulrike et al. (2021). “Medicinal Mushrooms for Prevention and Therapy of Osteoporosis (Review)..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
7. 7RTHM-00771·Kleftaki, Stamatia-Angeliki et al. (2022). “A Randomized Controlled Trial on Pleurotus eryngii Mushrooms with Antioxidant Compounds and Vitamin D2 in Managing Metabolic Disorders..” Antioxidants (Basel.Study breakdown →PubMed →↩